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Abstract 
Neuropathy is one of the most common complications in patients with diabetes mellitus (DM). Neuropathy has contributed to some impacts of quality of life
(QOL), general health status, and socio-economy level. Therefore, it is important to understand more about this issue, so appropriate treatment could be ta-
ken to improve QOL of patients with diabetic neuropathy. This study aimed to  measure the profile of a patient’s life quality in DM with neuropathy. This study
was a observational study using Short Form 8 (SF-8) Health Survey Standard Indonesia to measure the QOL in patients with diabetic neuropathy that were
treated consecutively from March to August 2016 in the Department of Neurology in Bethesda Hospital, Yogyakarta. By 57 patients with diabetic neuropathy
were enrolled as  subjects in this study. Most of them were  women (52,6%). The mean age of subjects was 57.3 ± 5.85 years. The lowest QOL score in pa-
tients with diabetic neuropathy were observed in general health perceptions category (45.26%), followed by bodily pain (57.19%), vitality or energy (69.12%),
physical functioning (69.82%), social role functioning (74.03%), mental health (78.59%), physical role functioning (80.70%), and emotional role functioning
(81.05%). Patients with diabetic neuropathy have poor QOL. Sex and age were not significantly related to the QOL in patients with diabetic neuropathy.
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Abstract
Neuropati merupakan salah satu komplikasi tersering pada diabetes melitus (DM). Neuropati dapat memengaruhi kualitas hidup, derajat kesehatan, maupun
tingkat ekonomi. Oleh karena itu, penting untuk mengetahui kualitas hidup pasien DM dengan neuropati beserta dampak yang ditimbulkannya terlebih dahu-
lu agar mendapatkan penanganan yang tepat demi meningkatkan kualitas hidup pasien. Penelitian ini bertujuan untuk mengetahui profil kualitas hidup pasien
DM dengan neuropati. Penelitian ini merupakan studi observasional menggunakan Short Form 8 (SF-8) Health Survey Standard Indonesia terhadap pasien
diabetes melitus dengan neuropati yang diambil secara konsekutif pada bulan Maret hingga Agustus 2016 di Poli Saraf Rumah Sakit Bethesda, Yogyakarta.
Terdapat 57 subjek yang dimasukkan dalam penelitian ini. Sebanyak 52,6 % di antaranya adalah perempuan dengan rerata usia 57,3 ± 5,85 tahun. Skor
kualitas hidup pasien neuropati DM yang paling rendah terdapat pada kategori kesehatan umum (45,26%) disusul nyeri pada tubuh (57,19%), vitalitas atau
energi (69,12%), fungsi fisik (69,82%), fungsi sosial (74,03%), kesehatan mental (78,59%), kemampuan peran dengan masalah kesehatan fisik (80,70%),
dan kemampuan peran dengan masalah emosi (81,05%). Jenis kelamin dan usia tidak berhubungan secara signifikan terhadap kualitas hidup pasien DM
dengan neuropati. 
Kata Kunci: Neuropati diabetika, kualitas hidup, Short Form 8 Health Survey
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Introduction 
Diabetes mellitus (DM) is one of the most common
chronic non-infectious diseases and the one of the lead-
ing public health problems in  modern society.1 Patients
with DM currently reach 380 million people worldwide
and this number will increase to 593 million in 2035.
Patients diagnosed with DM in Indonesia until 2013 was
6.9%, or about 12 million people. The prevalence of DM
complications also reportedly increased.2 Late complica-
tions of DM associated with high number of morbidity
and mortality caused by primary disease effect or secon-
dary complications.3 Proportion of patients with DM al-
so increases with age, and most common in women.4 The
incidence of DM also increased twice in the last third
decades of life and have a big impact on quality of life
(QOL), health status and economic levels.
Neuropathy is one of common complications in pa-
tients with type 1 and type 2 of DM.2 Diabetic neuropa-
thy is the presence of symptoms or signs of peripheral
nerve dysfunction of diabetic patients.5 Neuropathy can
be in many types, both focal and symmetrical type. The
most common forms are chronic, symmetrical, and
length-dependent axonal sensory-motor poly-neuropathy.
Most patients experience sensory symptoms either posi-
tive or negative symptoms, but some others apparently
asymptomatic. The symptoms can fluctuate over time.
Some of them experience pain associated with neuropa-
thy. There are also known as painful diabetic neuropathy
(PDN), which has strong ties with the other complica-
tions of diabetes.1,6
PDN is the most common cause of neuropathic pain
that can be clinically diagnosed. Symptoms are felt most-
ly in the area of the distal and symmetric (glove and
stocking pattern), associated with exacerbations at night,
and described as stabbed pain, electrical sensation, ten-
derness, and burning with hyperalgesia and allodynia
during the examination. PDN also makes wider impact
on other aspects such as sleep disturbance, mood, men-
tal status, and daily living activities that have negative ef-
fects on QOL, especially in physical function, decrease of
QOL over time, and improve health financing long
term.1,6-7
There are some instruments that can be used to assess
the QOL in patients with PDN such as the Short Form
(36) Health Survey or SF-36, SF-12, EQ-5D, and also SF-
8. Another instrument that identifies QOL associated
PDN specifically include PN-QOL-97, Norfolk QOL-DN,
and NeuroQol.8 The SF-8 was developed to replicate the
SF-36 with one question for each health domain. It co-
vers some points about general health perceptions, physi-
cal functioning, physical role functioning, bodily pain, vi-
tality (energy), social role functioning, mental health, and
emotional role functioning. SF-8 is proved to be reliable
and valid in assessing the general physical health and
mental health at population.9 The presence and severity
of neuropathic pain associated with degradation of the
QOL that can also give an impact on escalation of health
financing in long-term. The aim of this study was to mea-
sure the QOL of diabetic patients with neuropathy and
the impact of neuropathy.
Method
This study was an observational study using cross-sec-
tional analytic design. DM patients with neuropathy who
were treated consecutively from March to August 2016 in
Department Neurology of Bethesda Hospital, Yogyakarta
became the subject for this study. The inclusion criteria
were patients with DM with signs and symptoms of pe-
ripheral neuropathy, do not have a history of severe men-
tal illness, aged 18-65 years old, and willing to participate
in study.
The assessment of  QOL in diabetic patients with neu-
ropathy had used the SF-8 Health Survey Standard
Indonesia. SF-8 includes eight questions that each item is
intended to evaluate the QOL of diabetic patients with
neuropathy. The use of SF-8 is based on the previous
studies that show this brief questionaire is comparable
with SF-12 and SF-36. The brief questionnaire is advan-
tage in practical.10-11 The data are processed through de-
scriptive analysis and statistical computerized. Statistical
analysis includes a multivariate analysis of variance
(MANOVA) to identifying determinant factors of QOL in
patients with diabetic neuropathy.
Results 
The study involved 57 subjects who were qualified
for eligibility criteria. Table 2 shows female subjects were
30 (52.6%) and men were 27 (47.4%). The highest age
Table 1. SF 8 Health Survey Standard
Domain of SF 8 Health Survey Standard Answer Choices
General health perceptions Excellent/Very Good/Good/Fair/Poor/Very poor
Physical functioning Not at all/Very little/Somewhat/Quite a lot/Could not do physical activities
Physical role functioning Not at all/Very little/Somewhat/Quite a lot/Could not do daily work
Bodily pain None/Very mild/Mild/Moderate/Severe/Very severe
Vitality (energy) Very much/Quite a lot/Some/A little/None
Social role functioning Not at all/Very little/Somewhat/Quite a lot/Could not do social activities
Mental health Not at all/Slightly/Moderately/Quite a lot/Extremely
Emotional role functioning Not at all/Very little/Somewhat/Quite a lot/Could not do daily activities
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range 61-65 years (35.1%). The QOL in women was
slightly lower than men (Figure 1). In addition, the
youngest age range (41-45 years) had a better QOL than
other age ranges (Figure 2). Overall, statistical analysis
showed that there was  no  difference between
sex and age on the QOL of diabetic patients with neu-
ropathy.
Discussion 
This study showed that sex did not have a 
relation statistically with QOL of diabetic neuropathy pa-
tients, even though the much higher proportion of fe-
males than males with diabetic neuropathy symptoms
was shown by previous study (p value < 0.0001).12
Demographic factors and the patients’ records have a
negative impact on QOL among low education levels,
lack of employment, uncontrolled diabetes, and use of
therapeutic insulin.13
Based on age, duration of diabetes and neuropathy
clinical differences showed that women still had 50%
greater risk of experiencing more severe symptoms of
neuropathy than men.12 It is also compatible with this
study, the percentage of the average number on QOL of
women with DM neuropathy was lower than men, but
not statistically signicant. Previous study found that
women with diabetes had greater prevalence of occur-
rence for neuropathic pain. Pain and neuropathy are two
factors that 	 bring negative impact on QOL.
Previous study presented that demographic data and
medical history, such as low education levels, lack of em-
ployment, uncontrolled diabetes, and the use of insulin
therapy also had negative impact on the QOL of people.
Thus, it is important to be evaluated more.13,14
Earlier studies showed  that the risk factors of neuro-
pathic pain in diabetes was higher in elderly, low of socio-
economic status, insulin therapy using, long duration of
diabetes and bad glycemic control.15 Average age who
had diabetes with neuropathy in this study was 57.3 ±
5.85 years, which is almost the same as the average age
in the earlier study (57.2 ± 5.85 years).16 Socio-economic
status, duration of diabetes, history of the use of insulin
and glycemic control in this study were not evaluated.
General health status had the lowest percentage of
Table 2. Basic Characteristics of Patients with Diabetic Neuropathy, Mean of SF-
8 Score and the Result of Multivariate Analysis
Characteristic n (%) Mean of SF-8 Score p value
163.0)%74.96(16.4 ± 97.72xeS
Women 30 (52.6%) 27.40 ± 3.17 (68.5%)
Men 27 (47.4%) 28.22 ± 5.85 (70.55%)
Age (years)
41-45 3 (5.3%) 30.67 ± 2.31 (76.67%) 0.539
46-50 4 (7%) 28.00 ± 2.16 (70%) 1.000
51-55 12 (21.1%) 26.92 ± 3.23 (67.3%) 0.765
56-60 16 (28.1%) 27.00 ± 4.24 (67.5%) 0.779
61-65 20 (35.1%) 28.45 ± 6.05 (71.12%) 0.898
66-70 2 (3.5%) 28.00 ± 5.66 (70%) -
Mean of age  = 57.3 ±5.85 year
Figure 1. 	7 of Quality of Life in Patients with Diabetic Neuropathy Based on SF-8 Health Survey 
Standard Indonesia
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QOL in this study. Subjects assumed that their health
was quite disturbed by the presence of neuropathy.
Complications and comorbidities 	 decreased
QOL. Previous study showed hypertension disease as the
most chronic complication that had been frequently ap-
peared on elderly with DM. QOL of diabetic neuropathy
patients correlated with underlying disease state or co-
morbidities, such as hypertension and dyslipidemia that
may interfere patients’ ability function especially general
health status and patient’s QOL in general.13,17,18
Bodily pain is the second most impact to QOL in pa-
tients with diabetic neuropathy in this study. PDN is one
form of diabetes neuropathy that affects 16-34% of pa-
tients with diabetes. Experience of pain did not only be-
come a burden on the patient, but also become a se-
condary cause of disability due to the occurrence of sleep
disorders, mood disorders such as anxiety, and impaired
of physical function.19 Previous study also showed that
the  QOL of diabetic patients with neuropathic pain was
worse than the group without pain. The manifestations of
neuropathic pain associated with chronic back pain po-
tentially more intrusive than the DM disease themselves.1
Diabetes is associated with low physical function. It
was caused by peripheral nerve dysfunction. The pre-
sence of diabetes also accelerates the loss of muscle func-
tion and muscle protein synthesis as well as peripheral
nerve dysfunction which decreases mass and muscle
strength. It also  the occurrence of limitations
physical activity.20 In this study, the same results were
shown by physical function, followed by vitality/energy,
but physical role functioning was still in good range.
Good result from physical role functioning still need to
be further evaluated and compared to other factors, such
as duration of diabetes and the degree of neuropathic
pain because both of these also  the various
categories assessed in determining patients’ QOL.14
Neuropathic pain in diabetic patients have a role to
impaired functioning and mental health status because it
requires more time, energy and costs to get therapy. The
bad quality of mental health status in diabetic patients
with neuropathy also makes big impact to patients’  QOL
generally. The prior study reported that patients of dia-
betes with neuropathic pain actually had high levels of
depression, anxiety, and sleep disorders that were more
frequent than neuropathy without pain. The intensity of
pain and more severe intensity of depression are associ-
ated with low-income QOL.1 In this study, social func-
tion, mental health, and the ability roles with emotional
problems had higher percentage of QOL than other cate-
gories. It still needs to be studied further related to the
yield difference between the QOL of patients with DM
neuropathy pain and without pain. 
Based on the SF-8 Health Survey Standard Indonesia
Score, patients with diabetic neuropathy in this study
showed poor QOL in general health perceptions, bodily
pain, vitality (energy) and physical functioning, while
other category were still in good range. The QOL in dia-
betic patients is one of the most important aspects rela-
ted to life impacts, long-term prognosis, and the econo-
mic burden of the consequences. Therefore, it is neces-
sary to evaluate more about the symptoms and causes of
general health perceptions, physical functioning, physical
role functioning, bodily pain, vitality (energy), social role
functioning, mental health, and emotional role function-
ing issues for more appropriate management to improve
health and QOL in patients with diabetic neuropathy.
Conclusion 
Neuropathy in diabetic patients impairs their QOL. In
this study, the lowest QOL is shown by general health
perceptions, followed by bodily pain, vitality or energy
and physical functioning. Sex and age do not 
ly relate to the QOL in patients with diabetic neuropathy.
Further studies including a larger sample size should be
carried out to assess  impact on QOL in dia-
betic patients with neuropathy and effective management
of such impact.
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